Method for detecting ligand using FRET biosensor

Patent metadata

Field	Value
Publication number	US-9921215-B2
Application number	US-201013266753-A
Country	US
Kind code	B2
Filing date	Apr 27, 2010
Priority date	Apr 27, 2009
Publication date	Mar 20, 2018
Grant date	Mar 20, 2018

Abstract

The present application relates to a method for detecting ligand using a biosensor applied the FRET (fluorescence resonance energy transfer) phenomenon. More particularly, the method may be used for simply detecting a ligand in a sample by measuring the FRET of a biosensor under the conditions in which a specific critical temperature is maintained. The method may use a phenomenon in which a ligand-binding protein in a biosensor shows reversible unfolding at a temperature higher than the specific critical temperature and the level of the unfolding changes depending on the concentration of a ligand. The method can be widely applied to a variety of kinds of FRET biosensors using the ligand-binding protein.

First claim

What is claimed is:

1. A method of testing a sample, the method consisting of:
providing a FRET biosensor consisting of a fluorescence donor, a ligand-binding domain and a fluorescence acceptor in a single compound, wherein the ligand-binding domain is interposed between the fluorescence donor and the fluorescence acceptor;
bringing the FRET biosensor into contact with the sample to provide a mixture consisting of the FRET biosensor and the sample, wherein the sample may contain a ligand specific to the ligand-binding domain of the FRET biosensor;
applying, to the mixture, light beams having a wavelength for exciting the fluorescence donor, to generate light emission from the fluorescence acceptor;
measuring the light emission from the fluorescence acceptor; and
based on measurement of the light emission from the fluorescence acceptor, determining whether the sample contains the ligand, by change of the light emission from the fluorescence acceptor when the ligand is present and binds the ligand-binding domain of the FRET biosensor,
wherein said applying light beams and measuring light emission are performed at a temperature of from about 49° C. to about 54° C. in which the ligand-binding domain of the FRET biosensor is reversibly unfolded,
wherein when the ligand-binding domain of the FRET biosensor is a maltose-binding protein (MBP), said applying light beams and measuring light emission are performed when the ligand-binding domain of the FRET biosensor is reversibly unfolded at a temperature of about 54° C.,
wherein when the ligand-binding domain of the FRET biosensor is a galactose/glucose binding protein (GGBP), said applying light beams and measuring light emission are performed when the ligand-binding domain of the FRET biosensor is reversibly unfolded at a temperature of about 50° C., and
wherein when the ligand-binding domain of the FRET biosensor is an allose-binding protein (ALBP) or an arabinose-binding protein (ARBP), said applying light beams and measuring light emission are performed when the ligand-binding domain of the FRET biosensor is reversibly unfolded at a temperature of about 49° C.,
thereby assessing whether the sample includes a ligand of interest.

2. The method of claim 1 , wherein at least one of an acid, a base, a reducing agent, a denaturant (chaotropic agent), a stabilizer, a surfactant, an emulsifier and a detergent is added.

3. The method of claim 1 , wherein the ligand is selected from the group consisting of sugar, amino acid, protein, lipid, organic acid, metal or metal ions, oxide, hydroxide or its conjugates, inorganic ions, amine or polyamine, and vitamins.

4. The method of claim 1 , wherein the fluorescence donor is selected from the group consisting of fluorescent proteins, fluorescent dyes, bioluminescent proteins, and quantum dots, and the fluorescence acceptor is selected from the group consisting of fluorescent proteins, fluorescent dyes, and quantum dots, which have wavelengths different from those of the fluorescence donor.

5. The method of claim 1 , wherein the fluorescence donor is selected from the group consisting of fluorescent proteins, fluorescent dyes, bioluminescent proteins, and quantum dots, and the fluorescence acceptor comprises quenchers or Au-nano particles, which reduce the fluorescence intensity of the fluorescence donor.

Assignees

• Lee Seung Goo
• Ha Jae Seok
• Song Jae Jun
• Korea Res Inst Bioscience & Biotechnology

Inventors

• Lee Seung Goo
• Ha Jae Seok
• Song Jae Jun

Classifications

• G01N33/588

  with semiconductor nanocrystal label, e.g. quantum dots · CPC title

• G01N33/582

  with fluorescent label · CPC title

• G01N33/542 Primary

  with steric inhibition or signal modification, e.g. fluorescent quenching · CPC title

• G01N2500/00

  Screening for compounds of potential therapeutic value · CPC title

• G01N33/587

  Nanoparticles · CPC title